Triple-Action Anti-Glycation Mechanism Distinguishes Anglysin IB
Unlike conventional single-mode anti-glycation raw materials, Anglysin IB operates via three core pathways: inhibiting protein glycation and carbonylation, clearing preformed AGEs through autophagy, and blocking AGE-RAGE inflammatory signaling. Its natural blend of phenolic acids, flavonoids and sesquiterpenes targets the root drivers of glycation-induced skin decline.
Clinical Proof Reduces Skin Yellowing & Boosts Radiance
Human clinical evaluation validates Anglysin IB's visible benefits. Formulated at 0.1–1.5%, it lowers skin yellowness (b* value) and AGE biomarker levels, while improving skin brightness, dermal density and elasticity. These measurable gains address the dull, sallow complexion characteristic of advanced glycation in mature skin types.
Botanical Origin & Clean INCI Profile for Premium Formulations
Anglysin IB's INCI listing is Hydroxypropyl Cyclodextrin and *Inula Britannica* Flower Extract, sourced from sustainably harvested Inula blooms. The water-compatible active integrates smoothly into serums, creams and anti-aging concentrates, aligning with clean-beauty demands without compromising formulation stability or sensory experience.
Targeting Skin Longevity to Meet Premium Anti-Aging Demand
Consumers now seek longevity-focused actives beyond basic antioxidant care. Anglysin IB directly curbs glycation-driven fibroblast senescence and SASP signaling, preserving collagen and elastic matrix integrity. Its credible mechanistic and clinical data positions it for high-end anti-glycation, glow-repair and skin-longevity skincare ranges.
